Literature DB >> 67898

Evolutionary relationships between gag gene-coded proteins of murine and primate endogenous type C RNA viruses.

M Barbacid, J R Stephenson, S A Aaronson.   

Abstract

Several low molecular weight proteins of endogenous type C viruses of the RD114/baboon group are compared with the gag gene translational products of endogenous type C viruses of murine origin. The p10 proteins of each virus group are shown to be immunologically and biochemically related, while the p12 proteins of RD114/baboon viruses are demonstrated to share antigenic determinants with murine viral p15. Moreover, highly type-specific phosphoproteins, p15 of RD114/baboon viruses and p12 of murine viruses, are shown to possess very similar biochemical properties. These findings, along with previous studies indicating immunologic cross-reactivity between their major internal antigens, p30, demonstrate that each of the gag gene-coded proteins of murine type C viruses has a analogue in viruses of the RD114/baboon group. The immunologic and biochemical relatedness of their gag gene translational products supports the concept of a common progenitor in the evolution of these endogenous viruses.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 67898     DOI: 10.1016/0092-8674(77)90097-6

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  25 in total

1.  Pseudotypes of feline sarcoma virus contain an 85,000-dalton protein with feline oncornavirus-associated cell membrane antigen (FOCMA) activity.

Authors:  C J Sherr; A Sen; G J Todaro; A Sliski; M Essex
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

2.  Genomic diversity of the acquired immunodeficiency syndrome retroviruses is reflected in alteration of its translational products.

Authors:  S G Devare; A Srinivasan; C A Bohan; T J Spira; J W Curran; V S Kalyanaraman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

3.  Isolation of host-range variants of mouse mammary tumor viruses that efficiently infect cells in vitro.

Authors:  D K Howard; J Schlom
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

4.  Molecular cloning and primary nucleotide sequence analysis of a distinct human immunodeficiency virus isolate reveal significant divergence in its genomic sequences.

Authors:  S M Desai; V S Kalyanaraman; J M Casey; A Srinivasan; P R Andersen; S G Devare
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

5.  Major structural proteins of type B, type C, and type D oncoviruses share interspecies antigenic determinants.

Authors:  M Barbacid; L K Long; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

6.  Nucleotide sequence of the simian sarcoma virus genome: demonstration that its acquired cellular sequences encode the transforming gene product p28sis.

Authors:  S G Devare; E P Reddy; J D Law; K C Robbins; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

7.  Feline leukemia virus: biochemical and immunological characterization of gag gene-coded structural proteins.

Authors:  A S Khan; J R Stephenson
Journal:  J Virol       Date:  1977-09       Impact factor: 5.103

8.  Primate retroviruses: intracistronic mapping of type D viral gag gene by use of nonconditional replication mutants.

Authors:  S G Devare; J R Stephenson
Journal:  J Virol       Date:  1979-03       Impact factor: 5.103

9.  Human T-cell lymphotropic virus type III: immunologic characterization and primary structure analysis of the major internal protein, p24.

Authors:  J M Casey; Y Kim; P R Andersen; K F Watson; J L Fox; S G Devare
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

10.  DNA sequence relationship of the baboon endogenous virus genome to the genomes of other type C and type D retroviruses.

Authors:  M Cohen; N Rice; R Stephens; C O'Connell
Journal:  J Virol       Date:  1982-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.